市場調查報告書
商品編碼
1402437
全球減重手術設備市場評估:依設備類型、依手術、依最終用戶、按地區、機會、預測(2017-2031)Bariatric Surgery Devices Market Assessment, By Device Type, By Procedure, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球減重手術設備市場規模預計到2023年將達到22.1億美元,到2031年將達到33.8億美元,2024-2031年預測期間複合年增長率為5.44%。在醫學進步和全球肥胖流行等多種因素的推動下,市場目前正在經歷轉型。肥胖和相關健康問題(包括糖尿病和心臟病)的流行顯著增加了減重手術的需求。此外,技術和手術技術的進步引入了創新設備,提高了減肥手術的效率和安全性。在世界各地,每年有近 58 萬人接受減重手術。除了減重之外,這些手術還可以顯著改善許多與肥胖相關的健康問題,包括第 2 型糖尿病。儘管市場預計將成長,但它面臨著監管審批、手術成本和減肥藥物上市的挑戰。因此,市場充滿機會和挑戰,成長速度預計將保持強勁,反映出解決肥胖問題的迫切需求。
該市場顯示出顯著增長,主要是由於肥胖及其相關併發症的流行。肥胖是第五大死因。隨著肥胖症在全球持續增加,糖尿病、心血管疾病和代謝紊亂等疾病的發生率預計也會增加。減重手術已成為肥胖患者的重要治療選擇。隨著醫療保健提供者努力改善患者的治療效果和安全,減重手術需求的激增正在推動利用先進技術的創新減重手術設備的市場。
根據世界衛生組織 (WHO) 的數據,全球有超過 10 億人被歸類為肥胖,其中包括 6.5 億成年人、3.4 億年輕人和 3,900 萬名兒童。數量還在持續增加。世界衛生組織預測,到2025年,大約1.67億成人和兒童將因超重或肥胖而健康狀況不佳。
減重手術設備技術的進步透過提高準確性和患者治療結果徹底改變了市場。機器人輔助手術系統的使用使外科醫生能夠在手術過程中獲得精確度和控制力。這些機器人系統提供手術部位的可視化、增加的靈活性以及處理傳統腹腔鏡工具被認為困難或不可能的複雜手術的能力。此外,新型 Obalon 球囊和腹腔鏡可調節胃束帶等微創治療方法正在獲得認可,並正在徹底改變減重手術。這些手術涉及小切口和專用器械,可顯著減少對周圍組織的損傷,與開放性手術相比,疼痛更輕,恢復更快,併發症也更少。此外,加速復健外科(ERAS)方案的採用,包括貫穿整個手術過程的基於證據的策略,對於最大限度地減少併發症和促進康復至關重要,並且是該領域的持續趨勢。是沒有進化。
從設備類型來看,微創手術設備已成為微創和非侵入性手術的主導部分。這些設備為傳統開放性手術提供了一種侵入性較小的替代方案,從而徹底改變了手術領域,從而減少了患者的創傷,縮短了恢復時間並減少了併發症。微創手術設備包括腹腔鏡、套管針、機器人輔助系統等多種工具和設備,大大提高了手術過程的精確度、視覺化和效率。由於其多功能性和經過驗證的優點,它受到許多外科醫生的青睞,並在微創和非侵入性手術中佔有重要的市場份額。
北美在全球市場中地位突出,一直佔最高份額。這是由於多種因素強調了該地區在行業中的主導地位。北美肥胖及相關疾病的盛行率很高,這推動了對減重手術以及減重手術設備的需求。該地區強大的醫療基礎設施、創新技術和熟練的醫務人員進一步鞏固了該地區在減肥手術領域的領先地位。
此外,廣泛的研發活動以及對醫療創新的關注,導致先進減重手術設備的不斷發展和採用。美國 FDA 等監管機構在加速審批、確保安全標準、創造有利於市場成長的環境方面發揮著至關重要的作用。隨著人們對肥胖相關健康風險的認識不斷提高以及減肥手術的好處變得更加明顯,北美市場預計將保持其在全球格局中的突出地位。
本報告研究和分析了全球減重手術設備市場,提供市場規模和預測、市場動態以及主要參與者的現狀和前景。
With a CAGR of 5.44% for the forecast period between 2024 and 2031F, the size of the global market for bariatric surgical equipment was estimated at USD 2.21 billion in 2023 and is projected to reach USD 3.38 billion in 2031. The global market for bariatric surgery devices is currently undergoing a transformative phase, driven by a combination of factors that reflect the evolving landscape of healthcare and the growing prevalence of obesity around the globe. The demand for bariatric procedures is growing significantly due to the increasing prevalence of obesity and associated health problems including diabetes and heart disease. Additionally, ongoing advancements in technology and surgical techniques have introduced innovative devices that enhance the efficiency and safety of bariatric procedures. Globally, close to 580,000 individuals undergo bariatric surgery every year. Besides weight loss, these surgical procedures lead to substantial improvements of numerous health issues associated with obesity such as type 2 diabetes. Despite the promise of growth, the market faces challenges related to regulatory approvals, cost of procedure, and the launch of weight loss drugs. As a result, the market exhibits a dynamic landscape with opportunities and challenges, and the pace of growth is expected to remain strong, reflecting the urgency of addressing obesity.
The global bariatric surgery devices market is experiencing substantial growth, primarily due to the increasing prevalence of obesity and associated health complications. Obesity is the fifth leading cause of death. As obesity continues to rise worldwide, the incidence of conditions like diabetes, cardiovascular diseases, and metabolic disorders will increase. Bariatric surgery has become an important treatment option for obese patients. The surge in demand for bariatric procedures has driven the market for innovative and technologically advanced bariatric surgery devices, as healthcare providers strive to enhance patient outcomes and safety.
According to the World Health Organization (WHO), there are over 1 billion individuals globally who are classified as obese, comprising 650 million adults, 340 million adolescents, and 39 million children. The number is on a continual rise. WHO projects by 2025, around 167 million people, spanning both adults and children, will experience deteriorating health due to excess weight or obesity.
Technological advancements in bariatric surgery devices have revolutionized the market by enhancing precision and patient outcomes. The utilization of robotic-assisted surgery systems has allowed surgeons to achieve precision and control during procedures. These robotic systems offer improved visualization of surgical area, enhanced dexterity, and the ability to tackle complex surgeries that were once considered challenging or impossible with traditional laparoscopic tools. Moreover, the growing acceptance of minimally invasive treatments, such the novel obalon balloon and laparoscopic adjustable gastric banding, has revolutionized bariatric surgery. These techniques, involving small incisions and specialized instruments, significantly reduce trauma to surrounding tissues, leading to reduced pain, faster recovery, and fewer complications compared to open surgery. Additionally, the adoption of Enhanced Recovery After Surgery (ERAS) protocols, which consists of evidence-based strategies throughout the surgical journey, has been pivotal in minimizing complications and expediting recovery, further emphasizing the continual evolution of the field.
In July 2023, leading medical device manufacturer Genesis MedTech announced that the National Medical Products Administration (NMPA) of China approved the market release of its groundbreaking ArtiSential line of articulating laparoscopic instruments. With its ability to replicate a surgeon's wrist and finger movements, ArtiSential is a laparoscopic surgical instrument that offers several clinical benefits that improve surgical accuracy and results. The double-joint end-effector offers complete access to slender surgical sites with 360 degrees of rotation. The surgeon can experience an authentic endoscopic procedure due to its fully mechanical operation and tactile feedback conduction.
Based on device type, minimally invasive surgical devices have emerged as the dominant segment, amongst minimally invasive and non-invasive surgical procedures. These devices have revolutionized the field of surgery, as they offer less invasive alternatives to traditional open surgeries, resulting in reduced trauma to patients, shorter recovery times, and fewer complications. Minimally invasive surgical devices encompass a wide array of tools and equipment, including laparoscopes, trocars, and robotic-assisted systems, which have significantly enhanced the precision, visualization, and efficiency of surgical procedures. Their versatility and proven benefits have made them preferred choice for many surgeons, contributing to their substantial market share in both minimally invasive and non-invasive surgical settings.
North America holds a prominent position in the global bariatric surgery device market, consistently accounting for the highest share. It is attributed to several key factors that underscore the region's dominance in the industry. North America has high prevalence of obesity and related health conditions, which drives the demand for bariatric surgeries and, consequently, bariatric surgery devices. The region's robust healthcare infrastructure, innovative technology, and skilled medical professionals further contribute to its leadership in the field of bariatric surgery.
Moreover, extensive research and development activities, alongside a strong emphasis on healthcare innovation, have resulted in continuous evolution and adoption of advanced bariatric surgery devices. Regulatory bodies, such as FDA in the United States, play a pivotal role in expediting approvals and ensuring safety standards, fostering an environment conducive to market growth. As awareness about the health risks associated with obesity continue to grow and the benefits of bariatric surgery become more apparent, North American market for bariatric surgery devices is expected to maintain its prominent position in the global landscape.
Like many sectors of the healthcare industry, the global bariatric surgery devices market experienced a significant impact due to the COVID-19 pandemic. At the beginning of the pandemic, there was a sharp decrease in bariatric surgical procedures conducted globally. As hospitals and healthcare facilities worldwide redirected their resources and focused on the urgent needs of COVID-19 patients, the volume of elective and non-urgent surgeries, including bariatric procedures, declined. Restrictions on non-essential medical procedures, coupled with concerns over virus transmission, led to the postponement or cancellation of many bariatric surgeries. It resulted in a temporary reduction in demand for bariatric surgery devices and associated equipment. One-fifth of surgeons expressed hesitation to resume bariatric surgeries until the COVID-19 pandemic had ended completely.
The global bariatric surgery devices market is a fast-growing competitive market, with major players like Intuitive Surgical Inc., Johnson & Johnson, SPATZ FIGA, Inc., etc. These companies have innovative and technologically advanced solutions, robust research and development, and significant market shares. With the rising demand for minimally invasive surgeries, the market players are producing better solutions. The global bariatric surgery devices market is expected to grow, driven by the growing prevalence of obesity and related disorders, increasing preference for minimally invasive surgery and technological advancement.
In May 2023, Olympus announced the market release of POWERSEALTM Sealer/Divider for Europe, Middle East, and Africa (EMEA). This versatile and advanced bipolar device provides state-of-the-art sealing, dissection, and grasping capabilities for surgeons specializing in various medical fields, catering to both laparoscopic and open surgical procedures. It enhances Olympus' advanced energy portfolio, complementing the unique hybrid technology of THUNDERBEAT, further strengthening their offerings.
In May 2021, Standard Bariatrics announced the US Food and Drug Administration granting clearance for its innovative Titan SGS stapling technology, which is uniquely tailored for bariatric sleeve surgery. The groundbreaking design of the Titan SGS provides surgeons conducting sleeve gastrectomy procedures with the longest continuous staple cutline in the industry, with a length of 23 centimeters.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.